Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000054.xml
Pharmacopsychiatry 2004; 37(5): 239-240
DOI: 10.1055/s-2004-832600
DOI: 10.1055/s-2004-832600
Letter
© Georg Thieme Verlag KG Stuttgart · New York
Olanzapine Augmentation in Panic Disorder
A Case ReportFurther Information
Publication History
Received: 30.4.2003
Revised: 17.7.2003
Accepted: 15.9.2003
Publication Date:
10 September 2004 (online)
Chronic and treatment refractory cases of panic disorder are not uncommon. We report on a man completely remitted from panic disorder after olanzapine and paroxetine combined treatment, and the possible modulating anti-anxiety effect of olanzapine is discussed. Olanzapine augmentation in panic and other anxiety disorders is deserving of more clinical attention.
References
- 1 Etxebeste M, Aragues E, Malo P, Pacheco L. Olanzapine and panic attacks. Am J Psychiatry. 2000 Apr; 157(4) 659-60
- 2 Mathew S J, Coplan J D, Gorman J M. Management of treatment-refractory panic disorder. Psychopharmacol Bull. 2001 Spring; 35(2) 97-110
- 3 Nyberg S, Farde L, Halldin C. A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects. Neuropsychopharmacology. 1997; 16 1-7
- 4 Roy-Byrne P P, Cowley D S. Course and outcome in panic disorder: a review of recent follow-up studies. Anxiety. 1994 - 1995; 1(4) 151-60
- 5 Shelton R C, Tollefson G D, Tohen M ,. et al . A novel augmentation strategy for treating resistant major depression. Am J Psychiatry. 2001; 158 31-134
- 6 Work Group on Panic D isorder, American Psychiatric A ssociation. Practice guideline for the treatment of patients with panic disorder. Am J Psychiatry. 1998 May; 155(5 Suppl) 1-34
Iou-Lin Chao, M.D.
Department of Psychiatry
Taipei Veteran’s General Hospital
Taipei
Taiwan
Email: ilchao@vghtpe.gov.tw